Risk assessment health risks, significance

It is quite clear that traditional risk assessment and risk management approaches are not working sufficiently well in the field of chemicals policy, in particular not in cases of high uncertainty. The traditional approach could hardly deal with the early chemical problems, characterised by evident impacts such as acute effects, and is even less effective in the present situation, with globalised flows of articles that contain hazardous chemicals and the resulting complex chemical cocktail, which may cause diffuse but significant adverse effects on human health and the environment. 

A discussion of risk assessment and risk management is part of this chapter. Recently there has been a significant expansion of these concepts for managing safety and health. Many industries and organizations have adopted safety management systems, discussed further in Chapter 35. Safety management systems (SMS) incorporate risk assessment and risk management. 

This book is divided into five parts the problem, accidents, health risk, hazard risk, and hazard risk analysis. Part 1, an introduction to HS AM, presents legal considerations, emergency planning, and emergency response. This Part basically ser es as an oveiwiew to the more teclmical topics covered in the remainder of the book. Part 11 treats the broad subject of accidents, discussing fires, explosions and other accidents. The chapters in Parts 111 and Part IV provide introductory material to health and hazard risk assessment, respectively. Pai1 V examines hazaid risk analysis in significant detail. The thiee chapters in this final part include material on fundamentals of applicable statistics theory, and the applications and calculations of risk analysis for real systems. 

In considering pesticide residues, it was clearly shown that crops from organic production systems contain no or significantly lower levels of pesticide residues than crops from conventional systems (Baker et al., 2002). However, while some scientists are concerned about the potential health impacts from such residues (Porter et al., 1999 Benbrook, 2002), pesticide legislators maintain that current pesticide risk assessments and pesticide registration procedures are adequate and that residues below the current legal limits can not have a negative health impact in humans (e.g. PSD, 2006). 

Estimates of exposure levels posing minimal risk to humans (MRLs) have been made, where data were believed reliable, for the most sensitive noncancer end point for each exposure duration. MRLs include adjustments to reflect human variability and, where appropriate, the uncertainty of extrapolating from laboratory animal data to humans. Although methods have been established to derive these levels (Barnes et al. 1987 EPA 1989a), uncertainties are associated with the techniques. Furthermore, ATSDR acknowledges additional uncertainties inherent in the application of these procedures to derive less than lifetime MRLs. As an example, acute inhalation MRLs may not be protective for health effects that are delayed in development or are acquired following repeated acute insults, such as hypersensitivity reactions, asthma, or chronic bronchitis. As these kinds of health effects data become available and methods to assess levels of significant human exposure improve, these MRLs will be revised. 

Significance of the predicted impacts should be assessed in the process of impact evaluation or interpretation. At this stage the health risk estimates (quantitative and qualitative) are analyzed in terms of their acceptability against relevant regulatory and/or technical criteria environmental quality standards or exposure limits. 

Demidova, O. (2002). Use of Risk Assessment in Environmental Impact Assessment for Projects with Significant Health Implications Case Studies of UK Waste Incineration Developments, M.Sc. Thesis. Central European University, Budapest. 

Carmichael, N.G., H. Enzmann, I. Pate, and F. Waechter, 1997. The significance of mouse hver tumor formation for carcinogenic risk assessment results and conclusions from a survey of ten years of testing by the agrochemical industry. Environ. Health Perspect. 105 1196-1203. 

Recognizing the need of humans for clean air, the WHO Regional Office for Europe in 1987 published the first edition of the Air Quality Guidelines for Europe containing health risk assessments of 28 chemical air contaminants (WHO 1987). In 1993, air pollutants of special environmental and health significance to countries of the European Region were identified by a... 

The first step in risk assessment is to gather health-related information associated with an exposure. Ideally, hazard identification starts before there is significant use of the agent. The structure of the compound is compared with that of compounds with known toxicity profiles. Cell-based studies are often performed to screen for toxicity. Finally, animal bioassays and human studies are performed to characterize and develop a toxicity profile. Multiple health-related endpoints are evaluated to determine if the compound is associated with adverse effects. Advantages of animal studies include experimental control and accurate knowledge of the dose. 

A number of species have been designated hazardous air pollutants (HAPs) or toxic air contaminants (TACs). Most are directly emitted into the air, but some also have significant secondary sources, i.e., are formed by chemical reactions in air. Furthermore, the ultimate health impacts are determined not only by the emissions and formation of such compounds in air but also by their atmospheric fates. In short, some pollutants react in air to form less toxic species, whereas others form more toxic compounds. Thus, scientific risk assessments of these pollutants require an accurate and complete understanding of their atmospheric chemistry. Some specific examples are discussed in this chapter. 

---